a linear regression model to observed age-specific cancer incidence rates against observed years, then multiplying the projected age-specific rates by the age-specific population. The Joinpoint regression model was used to determine at which year the linear trend changed significantly.
Introduction
As the leading cause of death in Korea [1] , cancer has been the country's main public health concern since 1983. Over 224,000 patients were newly diagnosed with cancer in Korea, and one in four deaths is due to cancer [2] . Although the cancer registration system in Korea is highly efficient and it can provide nationwide cancer statistics within a relatively brief period, a lag time of at least 2 years is required to collect, compile, and analyze the data of a specific year. For planning and implementation of comprehensive cancer control programs, it is important to assess the number of new cases and deaths that are expected to occur during the current year. In this study, we report the projected cancer incidence and mortality for the year 2016 based on data from the 1990s through 2014. 
Materials and Methods
The Korean Ministry of Health and Welfare initiated a nationwide, hospital-based cancer registry, the Korea Central Cancer Registry (KCCR), in 1980. The history, objectives, and activities of the KCCR have been documented in detail elsewhere [3] . Incidence data from 1999 to 2013 were obtained from the Korea National Cancer Incidence Database. Cancer cases were classified according to the International Classification of Diseases for Oncology, 3rd edition [4] , and converted according to the International Classification of Diseases, 10th edition (ICD-10) [5] . Mortality data from 1993 to 2014 were acquired from Statistics Korea [1] . The cause of death was coded and classified according to ICD-10 [5] .
The cancer sites included in this study were (1) all cancers combined and (2) the 24 common cancers as follows: lip, oral cavity, and pharynx (C00-C14), esophagus (C15), stomach (C16), colon and rectum (C18-C20), liver and intrahepatic bile duct (liver) (C22), gallbladder and other parts of the biliary tract (gallbladder) (C23-C24), pancreas (C25), larynx (C32), lung and bronchus (lung) (C33-C34), breast (C50), cervix uteri (C53), corpus uteri (C54), ovary (C56), prostate (C61), testis (C62), kidney (C64), bladder (C67), brain and central nervous system (C70-C72), thyroid (C73), Hodgkin lymphoma (C81), non-Hodgkin lymphoma (C82-C85, C96), multiple myeloma (C90), leukemia (C91-C95), and others.
Population data from 1993 to 2015 were obtained from the resident registration population, reported by Statistics Korea. Data on the mid-year population, as of July 1 of the respective year, were analyzed. For the year 2016, however, we used population data as of December 31, 2015, because mid-2015 resident registration population data were not yet available at the time of analysis.
Due to the time required for data collection, compilation, quality control, and analysis, incidence and mortality data for a specific year are usually available 2-3 years later. Therefore, to provide an estimate of the nation's current cancer CNS, central nervous system. consecutive joinpoints. However, for thyroid cancer, which has recently shown significant decreasing trends, we selected three joinpoints, although the last segment had only three data points. We summarized the results by using crude rates (CRs) and age-standardized rates (ASRs) of cancer incidence and mortality. ASRs were standardized using the world standard population [9] and expressed as rates per 100,000 persons.
Results

Incidence
A total of 254,962 new cancer cases are anticipated in 2016 (Table 1 , Fig. 1) , with more male (n=131,224) than female (n=123,738) cancer patients expected in the coming year.
The projected CRs per 100,000 of all sites combined in 2016 are projected to be 511.2 and 482.3 in men and women, respectively. The projected ASRs per 100,000 of all sites combined are 340.0 and 298.8, respectively ( Table 2 ). In men, the five leading primary sites of cancer are expected to be the colon and rectum (CR, 91.2; ASR, 59.6), stomach (CR, 91.0; ASR, 59.0), lung (CR, 65.9; ASR, 42.3), liver (CR, 45.0; ASR, 29.1), and thyroid (CR, 43.7; ASR, 31.1), accounting for 65.9% of all new cancers in 2016.
In women, the five leading primary sites are expected to be the thyroid (CR, 133.5; ASR, 96.2), breast (CR, 79.3; ASR, 52.2), colon and rectum (CR, 56.8; ASR, 30.5), stomach (CR, 42.8; ASR, 23.5), and lung (CR, 31.8; ASR, 16.0), accounting for 71.4% of all new cancers (Fig. 1 Table 3 . Leukemia and thyroid cancer are expected to be the most common types of cancer in both genders for the 0-14 and 15-34 age groups. Stomach cancer is predicted to be the most prevalent in men aged 35-64 years, while lung cancer is expected to be more frequent in men aged 65 and over. Thyroid cancer is predicted to be the most common cancer in women 35-64 years of age, whereas colorectal cancer is expected to be the most prevalent in women aged 65 and over. These projections indicate that the incidences of stomach, lung, liver, colorectal, and prostate cancers will increase gradually with age for men. In women, the age-specific incidence rates of stomach, colorectal, liver, lung, and cervical cancers denote a rising trend in these cancers with age; however, the incidence of breast and thyroid cancer in women is expected to level off after the late 40s and early 50s, respectively (Fig. 2 ).
Mortality
It is estimated that 75,172 cancer deaths will occur in Korea in 2016 (Table 1, Fig. 1 ). The projected CRs per 100,000 of all sites combined in 2016 for men and women are projected to be 179.8 and 113.1, respectively, whereas the projected ASRs per 100,000 of all sites combined are expected to be 116.2 and 53.1, respectively ( Table 4 ). The predicted five leading cancer sites causing mortality in men are predicted to be lung (CR, 49.4; ASR, 31.2), liver (CR, 30.6; ASR, 19.7), colon and rectum (CR, 20.1; ASR, 13.0), stomach (CR, 17.1; ASR, 11.0), and pan-creas (CR, 11.2; ASR, 7.2). During the same period, lung cancer (CR, 18.8; ASR, 8.3) is projected to be the leading cancer site in women, causing mortality, followed by the colon and rectum (CR,13.9; ASR, 6.0), liver (CR, 10.9; ASR, 5.0), stomach (CR, 10.3; ASR, 4.5), and pancreas (CR, 10.2; ASR, 4.6).
The predicted age-specific mortality rates of the selected cancers for males and females in 2016 are shown in further detail in Fig 3. When examined by age, Korean men and women aged 60 and over are expected to have the highest mortality rates from lung cancer.
Conclusion
A total of 254,962 new cancer cases and 74,096 cancer deaths are expected to occur in Korea during 2016. The colorectal cancer is predicted to the most common cancer among male for the first time, followed by stomach, lung, liver, and thyroid cancers. Lung, liver, colorectal, stomach, and pancreatic cancers are expected to be the most common causes of cancer deaths among men. In women, the five leading primary sites are expected to be the thyroid, breast, colorectal, stomach, and lung cancers are anticipated to be the most prevalent, while lung, colorectal, liver, stomach, and pancreatic cancers are projected to be the most common causes of cancer-related deaths.
Cancer is currently one of the foremost public health concerns in Korea. Although cancer rates are anticipated to Kyu-Won Jung, Cancer Incidence and Mortality in Korea, 2016 VOLUME 48 NUMBER 2 APRIL 2016 457 decrease somewhat, but cancer burden will continue to increase with the aging of its population. The current projections of cancer incidence and mortality for 2016 represent an important resource for planning and evaluating cancer-control programs. As the estimates in this study are modelbased, these results should be interpreted with caution.
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